In experienced hands, holmium laser enucleation of the prostate in men with BPH with glands 200 grams or greater yields outcomes similar to those of simple open prostatectomy with much less morbidity, according to a retrospective review at a single center.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
2 Clarke Drive
Cranbury, NJ 08512